Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.5K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.5K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.6K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.6K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

751
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
751
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

926
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
926
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

2.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.3K
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

2.0K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Integrated Framework for the Implementation and Strengthening of Antimicrobial Stewardship Programs in Six Countries in Latin America.

Antibiotics (Basel, Switzerland)·2026
Same author

Antimicrobial Stewardship Programs in Chile: A Historical Overview.

Antibiotics (Basel, Switzerland)·2026
Same author

Cross-sectional survey to assess the status of antimicrobial stewardship programs in public Chilean hospitals.

Antimicrobial resistance and infection control·2026
Same author

Point Prevalence Survey of Antibiotic Use in Latin American Hospitals: 2022-2023.

Antibiotics (Basel, Switzerland)·2025
Same author

Maternal mortality in Panama from 1998 to 2022.

Revista panamericana de salud publica = Pan American journal of public health·2024
Same author

First-trimester cesarean scar pregnancy: a comparative analysis of treatment options from the international registry.

American journal of obstetrics and gynecology·2023
Same journal

[SARS-CoV-2 infection in people living with HIV. Topics on the global panorama and in Chile].

Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia·2022
Same journal

[First isolates of Enterobacter cloacae complex co-producing KPC and NDM in a second level hospital in City of Panama].

Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia·2022
Same journal

[Pneumonia by Pneumocystis jirovecii after COVID-19 in non-HIV patient].

Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia·2022
Same journal

[Colonic perforation and sepsis associated with Clostridium septicum as clinical presentation of colon cancer].

Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia·2022
Same journal

[Chromoblastomycosis. First allochthonous case treated in Chile].

Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia·2022
Same journal

[Isolation of Neisseria meningitidis in anorectal specimen in a men who have sex with men with uretritis and primary syphilis].

Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia·2022
See all related articles

Related Experiment Video

Updated: Apr 15, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

19.4K

[Risk groups for tuberculosis in Chile].

Tania Herrera

    Revista Chilena De Infectologia : Organo Oficial De La Sociedad Chilena De Infectologia
    |April 11, 2015
    PubMed
    Summary
    This summary is machine-generated.

    Tuberculosis incidence in Chile remains high, concentrated in vulnerable populations like those with HIV, foreigners, and incarcerated individuals. These high-risk groups, often with multiple risk factors, hinder TB elimination efforts.

    More Related Videos

    The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
    23:06

    The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

    Published on: August 11, 2008

    19.8K
    A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
    10:10

    A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

    Published on: October 5, 2015

    19.6K

    Related Experiment Videos

    Last Updated: Apr 15, 2026

    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
    10:04

    Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

    Published on: September 5, 2017

    19.4K
    The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
    23:06

    The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

    Published on: August 11, 2008

    19.8K
    A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
    10:10

    A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

    Published on: October 5, 2015

    19.6K

    Area of Science:

    • Public Health
    • Epidemiology
    • Infectious Diseases

    Context:

    • Tuberculosis (TB) presents a persistent global health challenge.
    • Chile faces stagnant TB incidence rates, failing to meet elimination goals.
    • Cases are increasingly concentrated within specific high-risk demographics.

    Purpose:

    • To analyze the epidemiological profile of tuberculosis in Chile.
    • To identify and quantify key risk groups contributing to TB burden.
    • To understand the clustering of risk factors within vulnerable populations.

    Summary:

    • Chile's TB incidence rate is 13 per 100,000, with no significant decline.
    • In 2013, 33% of TB cases were concentrated in risk groups.
    • Major risk factors include HIV co-infection (8.7%), foreign nationality (8.4%), and incarceration (3.9%).
    • Multiple risk factors are common, indicating vulnerable clusters.

    Impact:

    • Highlights the need for targeted interventions in high-risk groups.
    • Informs public health strategies for TB control in low-prevalence settings.
    • Emphasizes the importance of addressing social determinants of health in TB elimination.